HK1210722A1 - Method for producing extended-release potassium citrate wax matrix tablet - Google Patents

Method for producing extended-release potassium citrate wax matrix tablet

Info

Publication number
HK1210722A1
HK1210722A1 HK15111693.0A HK15111693A HK1210722A1 HK 1210722 A1 HK1210722 A1 HK 1210722A1 HK 15111693 A HK15111693 A HK 15111693A HK 1210722 A1 HK1210722 A1 HK 1210722A1
Authority
HK
Hong Kong
Prior art keywords
potassium citrate
matrix tablet
wax matrix
release potassium
producing extended
Prior art date
Application number
HK15111693.0A
Other languages
English (en)
Chinese (zh)
Inventor
溫德爾．
．門多薩
麗塔．約瑟菲娜．
．桑托斯
尤洛吉歐．
．辛格
肯尼．
．迪
Original Assignee
Endoza Wendell
Santos Rita Josefina
Sin H E Lo Io
Dee Kennie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endoza Wendell, Santos Rita Josefina, Sin H E Lo Io, Dee Kennie filed Critical Endoza Wendell
Publication of HK1210722A1 publication Critical patent/HK1210722A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Chemistry (AREA)
HK15111693.0A 2012-09-27 2015-11-27 Method for producing extended-release potassium citrate wax matrix tablet HK1210722A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2012/000013 WO2014051443A1 (en) 2012-09-27 2012-09-27 Method for producing extended-release potassium citrate wax matrix tablet

Publications (1)

Publication Number Publication Date
HK1210722A1 true HK1210722A1 (en) 2016-05-06

Family

ID=50388700

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111693.0A HK1210722A1 (en) 2012-09-27 2015-11-27 Method for producing extended-release potassium citrate wax matrix tablet

Country Status (10)

Country Link
US (1) US11033627B2 (xx)
EP (1) EP2900222B1 (xx)
JP (1) JP6150148B2 (xx)
KR (1) KR101812090B1 (xx)
CN (1) CN104661653B (xx)
ES (1) ES2639547T3 (xx)
HK (1) HK1210722A1 (xx)
PH (1) PH12015500467A1 (xx)
SG (1) SG11201502292WA (xx)
WO (1) WO2014051443A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9295659B2 (en) 2013-02-28 2016-03-29 United Laboratories, Inc. High dose extended-release potassium citrate wax matrix tablet
WO2016159897A1 (en) 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
WO2016159898A1 (en) 2015-04-01 2016-10-06 Ay Doğan Slow release composition comprising potassium citrate and magnesium citrate
KR102274835B1 (ko) * 2019-06-17 2021-07-08 주식회사 한국팜비오 포타슘 시트레이트 조성물을 포함하는 서방형 정제
KR102490581B1 (ko) 2020-10-30 2023-01-20 운해이엔씨(주) 기체,액체,유체 처리용 방전기능이 내장된 양자에너지 발생장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1658062A (en) * 1926-03-15 1928-02-07 United Shoe Machinery Corp Carnauba wax and the preparation thereof
US4966776A (en) 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
ZA882783B (en) * 1987-06-10 1988-10-20 Warner-Lambert Company Process for preparing a pharmaceutical composition
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
JP5026630B2 (ja) * 2000-03-31 2012-09-12 小林製薬株式会社 造粒粉体及びその製造方法及び圧縮成形固形物
MX2007013327A (es) * 2005-04-25 2008-04-21 Teva Pharma Formulaciones de liberacion prolongada.
US20080131504A1 (en) * 2006-12-01 2008-06-05 Mission Pharmacal Co. Short Term Slow Release Drug Delivery System
CN102240272B (zh) * 2010-05-13 2013-07-10 丽珠医药集团股份有限公司 一种枸橼酸钾缓释片及其制备方法
CN102488670B (zh) * 2011-12-22 2013-05-01 苏州东瑞制药有限公司 双重缓释枸橼酸钾缓释制剂的制备方法

Also Published As

Publication number Publication date
JP6150148B2 (ja) 2017-06-21
CN104661653A (zh) 2015-05-27
WO2014051443A1 (en) 2014-04-03
EP2900222B1 (en) 2017-06-14
JP2015531370A (ja) 2015-11-02
EP2900222A1 (en) 2015-08-05
EP2900222A4 (en) 2016-03-16
SG11201502292WA (en) 2015-04-29
US11033627B2 (en) 2021-06-15
PH12015500467B1 (en) 2015-04-20
US20150231267A1 (en) 2015-08-20
PH12015500467A1 (en) 2015-04-20
KR101812090B1 (ko) 2017-12-27
ES2639547T3 (es) 2017-10-27
CN104661653B (zh) 2017-07-14
KR20150074003A (ko) 2015-07-01

Similar Documents

Publication Publication Date Title
HK1260333A1 (zh) 鎂合金、其製造方法及其用途
GB2514071B (en) Shape memory alloy actuation apparatus
HK1200881A1 (en) Magnesium alloy, method for the production thereof and use thereof
SG11201406026TA (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
GB201010701D0 (en) Process for producing microcapsules
GB2489658B (en) Tablet press
SG11201503318PA (en) Method for microcontact embossing
EP2933034A4 (en) PRESSURE FORMING METHOD
SG11201504465TA (en) Ruthenium complex, method for producing same, and method for producing ruthenium-containing thin film
PL2757876T3 (pl) System uwalniający drapieżne roztocza dobroczynkowate i sposób jego wytwarzania
EP2857001A4 (en) PROCESS FOR MANUFACTURING TABLET AND TABLET
HK1210722A1 (en) Method for producing extended-release potassium citrate wax matrix tablet
EP2840156A4 (en) MAGNESIUM ALLOY AND METHOD FOR THE PRODUCTION THEREOF
EP2837619A4 (en) PROCESS FOR THE PRODUCTION OF BETA-ALCOXYPROPIONAMIDE
IL237075A0 (en) A method for the production of the hexahydropyropyranol derivative
ZA201400326B (en) Bouillon tablet process
EP2835437A4 (en) MAGNESIUM ALLOY, MAGNESIUM ALLOY MEMBER, AND METHOD FOR MANUFACTURING THE SAME, AND METHOD FOR USING THE MAGNESIUM ALLOY
IL238755B (en) A method for the production of carboxamides
EP2937406A4 (en) PROCESS FOR MANUFACTURING BRIQUETTE
EP2824130A4 (en) PROCESS FOR PRODUCING POLYDIALKYLSILANE
GB201201062D0 (en) Radiofluorination method
ZA201500438B (en) Method for producing microcarriers
EP2719377A4 (en) METHOD FOR PRODUCING MOUTH-FORMABLE TABLETS
EP2811029A4 (en) PROCESS FOR PRODUCING SCYLLO-INOSITOL
IL219622A (en) Continuous process for making microcapsules

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220925